HSDD: When Low Desire Becomes a Diagnosis
SaveHSDD, hypoactive sexual desire disorder, describes low or absent sexual desire lasting at least 6 months that causes real distress and is not explained by relationship conflict, medication, or another condition [1]. Desire that fluctuates without bothering you is normal, not a diagnosis. HSDD is common and has treatment options.
Last updated: July 2026
What exactly is HSDD?
HSDD is a recognized medical diagnosis, not a judgment about how much sex is normal. Defined in psychiatric and gynecologic guidelines, it describes ongoing lack of sexual thoughts, interest, or responsiveness that causes distress to the person experiencing it. The American College of Obstetricians and Gynecologists treats it as one of several female sexual dysfunctions, each requiring both symptoms and distress 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG definition of hypoactive sexual desire disorder within female sexual dysfunction, the requirement of symptoms for at least 6 months plus clinically significant distress, prevalence figures for low desire and distressing low desire, and approved treatments for premenopausal HSDD.
No threshold number of times per month defines it. Two women with identical sex lives can differ entirely in whether they have HSDD, because the deciding factor is personal distress, not frequency. A clinician also confirms the low desire is not fully explained by low desire tied to a relationship or another cause.
How do the distress and duration criteria work?
Two criteria turn common low desire into a diagnosis: how long it lasts and whether it distresses you. Diagnostic frameworks require symptoms present for at least 6 months and occurring in most or all sexual encounters, plus clinically significant distress 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG definition of hypoactive sexual desire disorder within female sexual dysfunction, the requirement of symptoms for at least 6 months plus clinically significant distress, prevalence figures for low desire and distressing low desire, and approved treatments for premenopausal HSDD. Both parts must be present; brief dips around stress, illness, or a new baby do not qualify.
The distress criterion matters because roughly 4 in 10 women report low desire at some point, yet only about 1 in 10 are distressed enough to meet HSDD criteria 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG definition of hypoactive sexual desire disorder within female sexual dysfunction, the requirement of symptoms for at least 6 months plus clinically significant distress, prevalence figures for low desire and distressing low desire, and approved treatments for premenopausal HSDD. Distress is what the diagnosis is built to capture. A woman untroubled by lower desire has no disorder, even if her interest sits well below what she once felt.
What causes HSDD, and does it change with age?
HSDD usually has more than one root, blending biological, psychological, and relational factors. Contributors include depression and anxiety, medication side effects, chronic illness, fatigue, past negative sexual experiences, and hormonal shifts. Because the causes overlap, treatment is rarely a single fix.
Life stage shapes the picture. Desire commonly dips in the months after childbirth and during the perimenopausal transition, when falling estrogen adds vaginal dryness and discomfort 2Ref 2The North American Menopause Society (Menopause Society) (2020).The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.Menopause Society statement that falling estrogen in the menopause transition drives genitourinary symptoms including vaginal dryness and discomfort that reduce sexual interest. Generalized HSDD, present across situations and partners, is distinguished from acquired HSDD that starts after a period of normal desire. In adolescence, low desire is far more often about context and inexperience than a desire disorder.
How is HSDD treated?
Treatment for HSDD targets the contributing factors first, then desire specifically if needed. Reviewing medications, treating depression or sleep problems, addressing pain with sex, and, for some couples, sex therapy or counseling form the foundation. When low desire persists after those steps, desire-specific options exist.
For postmenopausal women with HSDD, an international society consensus supports a trial of testosterone, the only evidence-based hormonal indication for female desire, though no female product is FDA-approved 3Ref 3Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that a testosterone trial is evidence-based only for postmenopausal women with diagnosed HSDD, with no approved female product. Menopausal hormone therapy offers a small to moderate improvement in sexual function for symptomatic women, according to a Cochrane review 4Ref 4Nastri CO, Lara LA, Ferriani RA, et al. (2013).Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane review finding menopausal hormone therapy produces a small to moderate improvement in sexual function for symptomatic women. Two prescription medications are approved specifically for premenopausal HSDD, and a clinician can explain where each fits 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG definition of hypoactive sexual desire disorder within female sexual dysfunction, the requirement of symptoms for at least 6 months plus clinically significant distress, prevalence figures for low desire and distressing low desire, and approved treatments for premenopausal HSDD.
When to see someone about HSDD
HSDD is worth raising whenever low desire has lasted months and genuinely bothers you. A clinician can confirm the diagnosis, rule out thyroid problems, depression, and medication effects, and discuss options ranging from counseling to approved medications 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG definition of hypoactive sexual desire disorder within female sexual dysfunction, the requirement of symptoms for at least 6 months plus clinically significant distress, prevalence figures for low desire and distressing low desire, and approved treatments for premenopausal HSDD. Bringing up sex in a medical visit is routine, and starting that conversation is often easier than expected.
A primary care clinician or gynecologist can begin the workup, and referral to a menopause or sexual health specialist is available when needed. Distress, not a target number of encounters, is the signal that evaluation may help. Gale can help you prepare for that conversation.
Common questions
Related
Sexual health
Testosterone for Low Desire: What Evidence SupportsSexual health
Low Desire: When It's Worth a Medical VisitSexual health
Low Libido in Women: What's Behind the Change
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When low desire needs evaluation
- —Low desire paired with persistent sadness, hopelessness, or loss of interest in most activities, which is a reason to seek a mental health evaluation; if you have thoughts of self-harm, call or text 988
- —Pain or bleeding with sex that makes intimacy distressing, which is a reason to seek clinician review
- —Low desire that began with a new medication, which is a reason to ask a clinician for a medication review
- —Sudden loss of desire with fatigue, cold intolerance, or hair changes, which can point to a thyroid problem worth evaluating with a clinician
This article is general health education, not a diagnosis. Whether low desire meets criteria for HSDD, and what might help, are decisions to make with a primary care clinician or gynecologist.
References
- 1.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003324 ✓ACOG definition of hypoactive sexual desire disorder within female sexual dysfunction, the requirement of symptoms for at least 6 months plus clinically significant distress, prevalence figures for low desire and distressing low desire, and approved treatments for premenopausal HSDD
- 2.The North American Menopause Society (Menopause Society) (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000001609 ✓Menopause Society statement that falling estrogen in the menopause transition drives genitourinary symptoms including vaginal dryness and discomfort that reduce sexual interest
- 3.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓International consensus that a testosterone trial is evidence-based only for postmenopausal women with diagnosed HSDD, with no approved female product
- 4.Nastri CO, Lara LA, Ferriani RA, et al. (2013). Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009672.pub2 ✓Cochrane review finding menopausal hormone therapy produces a small to moderate improvement in sexual function for symptomatic women
4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy